These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 9514638)
21. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. Canvin JR; Marvin AP; Sivakumaran M; Paton JC; Boulnois GJ; Andrew PW; Mitchell TJ J Infect Dis; 1995 Jul; 172(1):119-23. PubMed ID: 7797901 [TBL] [Abstract][Full Text] [Related]
22. Streptococcus pneumoniae produces a second haemolysin that is distinct from pneumolysin. Canvin JR; Paton JC; Boulnois GJ; Andrew PW; Mitchell TJ Microb Pathog; 1997 Mar; 22(3):129-32. PubMed ID: 9075215 [TBL] [Abstract][Full Text] [Related]
24. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Kadioglu A; Taylor S; Iannelli F; Pozzi G; Mitchell TJ; Andrew PW Infect Immun; 2002 Jun; 70(6):2886-90. PubMed ID: 12010976 [TBL] [Abstract][Full Text] [Related]
25. Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea. Johnson MK; Callegan MC; Engel LS; O'Callaghan RJ; Hill JM; Hobden JA; Boulnois GJ; Andrew PW; Mitchell TJ Curr Eye Res; 1995 Apr; 14(4):281-4. PubMed ID: 7606914 [TBL] [Abstract][Full Text] [Related]
26. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin. Cruse G; Fernandes VE; de Salort J; Pankhania D; Marinas MS; Brewin H; Andrew PW; Bradding P; Kadioglu A J Immunol; 2010 Jun; 184(12):7108-15. PubMed ID: 20483738 [TBL] [Abstract][Full Text] [Related]
28. Amino acids in pneumolysin important for hemolytic activity identified by random mutagenesis. Hill J; Andrew PW; Mitchell TJ Infect Immun; 1994 Feb; 62(2):757-8. PubMed ID: 8300240 [TBL] [Abstract][Full Text] [Related]
29. [Selection of virulent mutants of Streptococcus pneumoniae. Utilization of a murine model of septicemia]. Amory-Rivier C; Rieux V; Azoulay-Dupuis E; Carbon C; Trombe MC Pathol Biol (Paris); 1999 May; 47(5):519-25. PubMed ID: 10418032 [TBL] [Abstract][Full Text] [Related]
30. Construction of a pneumolysin deficient mutant in streptococcus pneumoniae serotype 1 strain 519/43 and phenotypic characterisation. Terra VS; Plumptre CD; Wall EC; Brown JS; Wren BW Microb Pathog; 2020 Apr; 141():103999. PubMed ID: 31996316 [TBL] [Abstract][Full Text] [Related]
31. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. Rijneveld AW; van den Dobbelsteen GP; Florquin S; Standiford TJ; Speelman P; van Alphen L; van der Poll T J Infect Dis; 2002 Jan; 185(1):123-6. PubMed ID: 11756992 [TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A. Song M; Teng Z; Li M; Niu X; Wang J; Deng X J Cell Mol Med; 2017 Oct; 21(10):2586-2598. PubMed ID: 28402019 [TBL] [Abstract][Full Text] [Related]
33. Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. Jefferies JM; Johnston CH; Kirkham LA; Cowan GJ; Ross KS; Smith A; Clarke SC; Brueggemann AB; George RC; Pichon B; Pluschke G; Pfluger V; Mitchell TJ J Infect Dis; 2007 Sep; 196(6):936-44. PubMed ID: 17703426 [TBL] [Abstract][Full Text] [Related]
34. The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Johnson MK; Hobden JA; Hagenah M; O'Callaghan RJ; Hill JM; Chen S Curr Eye Res; 1990 Nov; 9(11):1107-14. PubMed ID: 2095322 [TBL] [Abstract][Full Text] [Related]
35. Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3. Berry AM; Paton JC; Hansman D Microb Pathog; 1992 Feb; 12(2):87-93. PubMed ID: 1350046 [TBL] [Abstract][Full Text] [Related]
36. Protection against bacteremic pneumococcal infection by antibody to pneumolysin. Musher DM; Phan HM; Baughn RE J Infect Dis; 2001 Mar; 183(5):827-30. PubMed ID: 11181163 [TBL] [Abstract][Full Text] [Related]
37. Differential gene expression in Streptococcus pneumoniae in response to various iron sources. Gupta R; Shah P; Swiatlo E Microb Pathog; 2009 Aug; 47(2):101-9. PubMed ID: 19464356 [TBL] [Abstract][Full Text] [Related]
38. Clarithromycin Inhibits Pneumolysin Production via Downregulation of Domon H; Isono T; Hiyoshi T; Tamura H; Sasagawa K; Maekawa T; Hirayama S; Yanagihara K; Terao Y Microbiol Spectr; 2021 Oct; 9(2):e0031821. PubMed ID: 34468195 [TBL] [Abstract][Full Text] [Related]
39. Designed reduction of Streptococcus pneumoniae pathogenicity via synthetic changes in virulence factor codon-pair bias. Coleman JR; Papamichail D; Yano M; García-Suárez Mdel M; Pirofski LA J Infect Dis; 2011 May; 203(9):1264-73. PubMed ID: 21343143 [TBL] [Abstract][Full Text] [Related]
40. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Cockeran R; Anderson R; Feldman C Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]